Chronotype preference, sleep quality, and night-eating behaviors in patients with metabolic dysfunction-associated steatotic liver disease: Assessing the relationship with disease severity and fibrosis [0.03%]
代谢功能障碍相关肝脂肪变性患者的生物钟类型偏好、睡眠质量和夜间进食行为与疾病严重程度和纤维化的关系评估
Ayse Sakalli Kani,Ahmet Ozercan,Haluk Tarik Kani et al.
Ayse Sakalli Kani et al.
Background and aim: Our primary objective is to examine the variance in chronotype, night-eating patterns, and sleep quality in patients with biopsy-proven metabolic dysfunction-associated steatotic liver disease. In addi...
The efficacy and tolerability of glecaprevir/pibrentasvir treatment in a real-world chronic hepatitis C patients cohort [0.03%]
Grazoprevir/elbasvir治疗现实世界慢性丙型肝炎患者的有效性和耐受性
Serkan Yaras,Mehmet Demir,Sezgin Barutcu et al.
Serkan Yaras et al.
Background and aim: The aims of the present study were to evaluate the real-life efficacy and tolerability of glecaprevir (GLE)/pibrentasvir (PIB) in the treatment of patients with chronic hepatitis C (CHC). ...
Protective/preventive effects of quercetin against cyclophosphamide-induced hepatic inflammation, apoptosis and fibrosis in rats [0.03%]
檞皮素对环磷酰胺致大鼠肝炎、肝细胞凋亡及肝纤维化的保护作用研究
Sibel Turedi
Sibel Turedi
Background and aim: The purpose of this study was to investigate the hepatoprotective effects of quercetin, a potent antioxidant, against hepatotoxicity caused by cyclophosphamide (CYC) in the rat liver using histopatholo...
Yusuf Yilmaz
Yusuf Yilmaz
Prevalence and predictors of metabolic-associated fatty liver disease in liver transplant recipients: A cross-sectional prospective study [0.03%]
肝移植受者中与代谢相关性脂肪性肝病的流行率及预测因素：一项横断面研究
Gupse Adali,Nermin Mutlu Bilgic,Ahmet Emre Kalaman et al.
Gupse Adali et al.
Background and aim: Metabolic-associated fatty liver disease (MAFLD) has emerged as a significant global health concern. However, the prevalence and predictors of MAFLD in post-liver transplantation (LT) patients remain u...
Should dermatologists care about hepatic fibrosis and steatosis? Psoriasis first, hidradenitis suppurativa second [0.03%]
皮肤科医生应该关注肝纤维化和脂肪变性吗？银屑病第一，化脓性汗腺炎第二
Enzo Emanuele,Piercarlo Minoretti
Enzo Emanuele
Bioinformatic analysis of genetic changes CLOCK, BMAL1, CRY1, CRY2, PER1, PER2, PER3, and NPAS2 proteins in HCC patients [0.03%]
乙型肝炎相关性原发性肝癌患者CLOCK、BMAL1、CRY1、CRY2、PER1、PER2、PER3及NPAS2基因多态性生物信息学分析
Durmus Ayan,Ak Cagatay
Durmus Ayan
Background and aim: Genes related to the circadian rhythm control various biological processes. The aim of this study was to comprehensively investigate the mutational and mRNA profile of core circadian rhythm genes in he...
A new method for predicting alcohol relapse in patients undergoing liver transplantation for alcohol-related liver failure: Barratt scale [0.03%]
巴雷特量表：酒精性肝硬化患者肝移植术后预测饮酒复发的新方法
Veysel Umman,Tufan Gumus,Ebubekir Korucuk et al.
Veysel Umman et al.
Background and aim: Alcohol-induced liver disease has become one of the major causes of chronic liver disease worldwide with the increasing use of alcohol in society. The most important step in treatment is cessation of a...
Practice patterns and considerations in liver transplantation from living donors with high BMI: A review [0.03%]
肥胖供肝活体肝脏移植临床实践及考量：一篇综述
Carl Samaha,Hadi Chaaban,Cem Simsek et al.
Carl Samaha et al.
Living Donor Liver Transplantation (LDLT) is a valuable solution to the shortage of donor organs for patients with end-stage liver disease. However, the eligibility of obese donors for LDLT remains a subject of debate. This literature revie...
Incidental combined hepatocellular-cholangiocarcinoma in liver transplant patients: Does it have a worse prognosis? [0.03%]
肝移植患者的意外混合型肝细胞-胆管癌：预后更差吗？
Ender Anilir,Alihan Oral,Tolga Sahin et al.
Ender Anilir et al.
Background and aim: Combined hepatocellular-cholangiocarcinoma (CHC) requires attention clinically and pathologically after liver transplantation (LT) because of its unique biology, difficulties in diagnosis, and being ra...